P. Bisel, E. Breitling, A. W. Frahm
FULL PAPER
in vacuo and the crude residue was used for the subsequent reac-
tion without further purification.
(1S,2R)- and (1R,2S)-2-Benzyloxycyclobutanamine Hydrochlo-
rides (8a,b): 10% Pd/C (25 mg) was suspended in ethanol (50 ml)
and prehydrogenated at 5 bar and 45°C for 15 min. The amine
hydrochloride 5 (800 mg, 2.5 mmol) in ethanol (75 ml) was then
added and hydrogenolysis was allowed to proceed for 24 h. The
catalyst was then removed by filtration through Celite, and the fil-
trate was concentrated. Recrystallization of the residue from ethyl
acetate afforded 8 (375 mg, 1.75 mmol, 70%) as white crystals. Ϫ
(1S,2R)- and (1R,2S)-2-Benzyloxy-N-(1-phenylethyl)cyclobut-
anamine Hydrochlorides (5a,b): The crude imine 4 (14.0 g, 0.05 mol)
was taken up in absolute ethanol (50 ml) and 2.0 g of ethanol-
treated Raney nickel was added. Hydrogenation was carried out at
5 bar and room temperature for 40 h in a Parr hydrogenator. The
catalyst was then removed by filtration through Celite and the fil-
trate was concentrated. The residue was purified by means of flash
chromatography, with elution by cyclohexane/ethyl acetate, 7.5:2.5.
The crude amine was obtained in 60Ϫ70% yield and was precipi-
tated as its hydrochloride in HCl-saturated diethyl ether. Recrystal-
lization from ethyl acetate afforded 5 (5.08 g, 16 mmol, 32%) as
8a: M.p. 153°C. Ϫ [α]25 ϭ Ϫ20.4. Ϫ C11H16ClNO (197.7): calcd.
D
C 61.8, H 7.55, N 6.55; found C 61.7, H 7.42, N 6.55. Ϫ 8b: M.p.
155°C. Ϫ [α]25 ϭ ϩ20.9. Ϫ C11H16ClNO (197.7): calcd. C 61.8,
D
H 7.55, N 6.55; found C 61.5, H 7.53, N 6.53. Ϫ 1H NMR (CDCl3,
300 MHz): δ ϭ 2.00 (m, 1 H, 4-H), 2.08 (m, 1 H, 4-H), 2.12 (m, 1
H, 3-H), 2.48 (m, 1 H, 3-H), 3.84 (m, 1 H, 1-H), 4.11 (q, J ϭ 6.6
Hz, 1 H, 2-H), 4.49 (d, J ϭ 12.2 Hz, 1 H, PhCH2), 4.69 (d, J ϭ
12.2 Hz, 1 H, PhCH2), 7.25 (m, 3 H, ArH), 7.39 (m, 2 H, ArH),
8.6 (br. s, 3 H, NH3ϩ). Ϫ 13C NMR (CDCl3, 75 MHz): δ ϭ 20.5
(C-4), 26.5 (C-3), 49.9 (C-1), 70.7 (PhCH2), 71.2 (C-2), 127.6 (ArC),
127.8 (ArC), 128.3 (ArC), 137.5 (ArC).
white crystals. Ϫ 5a: M.p. 145°C. Ϫ [α]25 ϭ ϩ115.6.
Ϫ
D
C19H24ClNO (317.8): calcd. C 71.8, H 7.61, N 4.39; found C 71.7,
H 7.57, N 4.41. Ϫ 5b: M.p. 145°C. Ϫ [α]25 ϭ Ϫ114.6. Ϫ
D
C19H24ClNO (317.8): calcd. C 71.8, H 7.61, N 4.39; found C 71.7,
1
H 7.68, N 4.44. Ϫ H NMR (CDCl3, 300 MHz): δ ϭ 1.94 (d, J ϭ
6.8 Hz, 3 H, CH3), 1.97 (m, 1 H, 3-H), 2.12 (m, 1 H, 4-H), 2.58
(m, 1 H, 3-H), 2.77 (m, 1 H, 4-H), 3.38 (m, 1 H, 1-H), 4.40 (d,
JAB ϭ 12 Hz, 1 H, PhCH2), 4.06 (m, 1 H, 2-H), 4.81 (d, JAB ϭ 12
Hz, 1 H, PhCH2), 7.2Ϫ7.6 (m, 10 H, ArH), 10.0 (br. s, 1 H,
NH2ϩ), 10.5 (br. s, 1 H, NH2ϩ). Ϫ 13C NMR (CDCl3, 75 MHz):
δ ϭ 20.8 (CH3), 21.7 (C-4), 24.6 (C-3), 52.3 (C-1), 58.4 (C-α), 69.7
(PhCH2), 72.1 (C-1), 127.7 (ArC), 128.1 (ArC), 128.2 (ArC), 128.4
(ArC), 128.8 (ArC), 129.0 (ArC), 136.7 (ArC), 137.4 (ArC).
General Procedure for Conversion to the Mosher Amides 9a,b (and
10a,b): The primary amine hydrochlorides 6a,b (or 8a,b) (0.15
mmol) were taken up in CHCl3 (1 ml), pyridine (2 ml) was added,
followed by (S)-(ϩ)-2-methoxy-2-phenyl-2-trifluoromethylethanoyl
chloride (0.30 mmol) (0.15 mmol for 8a,b). Stirring was maintained
for 18 h. The solvent was then removed in vacuo, the residue was
taken up in H2O (3 ml) and extracted with diethyl ether (3 ϫ 5
ml). The combined organic extracts were washed with 1 HCl (5
ml), a saturated solution of Na2CO3 (5 ml) and H2O, dried, and
concentrated in vacuo. The crude residue was analyzed by 19F-
NMR spectroscopy.
(1R,2S)- and (1S,2R)-2-Aminocyclobutanol Hydrochlorides
(6a,b): 10% Pd/C (250 mg) was suspended in ethanol (50 ml) and
prehydrogenated at 5 bar and 45°C for 15 min. The amine hydro-
chloride 5 (800 mg, 2.5 mmol) in ethanol (75 ml) was then added
and hydrogenolysis was allowed to proceed for 24 h. The catalyst
was then removed by filtration through Celite, the filtrate was con-
centrated, and the residue was recrystallized from ethyl acetate to
yield 6 (247 mg, 2.0 mmol, 80%) as white crystals. Ϫ 6a: M.p.
General Procedure for the Conversion to the Salicylidene Deriva-
tives 11a,b: The primary amine hydrochlorides 8a,b (0.3 mmol)
were taken up in MeOH (2 ml), and sodium 2-formylphenolate (0.3
mmol) was added. The mixture was refluxed for 15 min and then
allowed to stand at room temperature overnight. The solvent was
removed in vacuo and the residue was submitted to CD spec-
troscopy.
115Ϫ117°C. Ϫ [α]25 ϭ ϩ4.0. Ϫ C4H10ClNO (123.6): calcd. C
D
38.9, H 8.16, N 11.33; found C 38.7, H 7.97, N 11.26. Ϫ 6b: M.p.
116Ϫ118°C. Ϫ [α]25 ϭ Ϫ6.8. Ϫ C4H10ClNO (123.6): calcd. C
D
38.9, H 8.16, N 11.33; found C 38.3, H 8.04, N 11.05. Ϫ 1H NMR
(CD3OD, 300 MHz): δ ϭ 2.05 (m, 1 H, 4-H), 2.10 (m, 1 H, 3-H),
2.20 (m, 1 H, 4-H), 2.30 (m, 1 H, 3-H), 3.78 (m, 1 H, 1-H), 4.45
(m, 1 H, 2-H). Ϫ 13C NMR (CD3OD, 75 MHz): δ ϭ 22.0 (C-4),
29.0 (C-3), 51.6 (C-1), 66.5 (C-2).
[1]
´
R. A. Aitken, S. N. Kilenyi, Asymmetric Synthesis, University
Press, Cambridge, 1992, 83Ϫ142, and references cited therein.
C. G. Overberger, N. P. Marullo, R. G. Hiskey, J. Am. Chem.
Soc. 1961, 83, 1374Ϫ1378.
[2]
[3]
[3a] G. Knupp, A. W. Frahm, Chem. Ber. 1984, 117, 2076. Ϫ
[3b]
[3c]
W. Wiehl, A. W. Frahm, Chem. Ber. 1986, 119, 2668. Ϫ
C.
(1R,2S)- and (1S,2R)-2-[(1-Phenylethyl)amino]cyclobutanol
Hydrochlorides (7a,b): 10% Pd/C (250 mg) was suspended in etha-
nol (50 ml) and prehydrogenated at 5 bar and room temperature
for 15 min. The amine hydrochloride 5 (800 mg, 2.5 mmol) in etha-
nol (75 ml) was then added and hydrogenolysis was allowed to pro-
ceed for 24 h. The catalyst was then removed by filtration through
Celite, and the filtrate was concentrated. Recrystallization of the
residue from ethyl acetate afforded 7 (284 mg, 1.25 mmol, 50%)
M. Nachtsheim, A. W. Frahm, Arch. Pharm. 1989, 322,
199Ϫ206. Ϫ [3d] For the influence of the reducing agent and the
catalyst on the diastereo- and enantioselectivity see: G. Knupp,
A. W. Frahm, Arch. Pharm. 1985, 318, 250Ϫ257.
[4] [4a]
T. A. Lyle, C. M. Wiscount, J. P. Guare, W. J. Thompson,
P. S. Anderson, P. L. Darke, J. A. Zugay, E. A. Emini, W. A.
Schleif, J. C. Quintero, R. A. F. Dixon, I. S. Sigal, J. R. Huff,
J. Med. Chem. 1991, 34, 1230Ϫ1233. Ϫ [4b] B. D. Dorsay, R. B.
Lewin, S. L. McDaniel, J. Vacca, J. P. Guare, P. L. Darke, J. A.
Zugay, E. A. Emini, W. A. Schleif, J. C. Quintero, J. H. Lin, Y.-
W. Chen, M. R. Holloway, P. M. D. Fitzgerald, M. G. Axel, D.
Ostovich, P. Anderson, J. R. Huff, J. Med. Chem. 1994, 37,
3443Ϫ3451.
as white crystals. Ϫ 7a: M.p. 121Ϫ123°C. Ϫ [α]25 ϭ Ϫ64.1. Ϫ
D
C12H18ClNO (227.7): calcd. C 63.3, H 7.97, N 6.15; found C 63.2,
H 7.85, N 6.15. Ϫ 7b: M.p. 122°C. Ϫ [α]25 ϭ ϩ65.2. Ϫ
D
[5]
[6]
C12H18ClNO (227.7) : calcd. C 63.3, H 7.97, N 6.15; found C 63.2,
D. J. Ager, I. Prakash, D.R. Schaad Chem. Rev. 1996, 96,
835Ϫ875.
1
H 8.02, N 6.13. Ϫ H NMR (CDCl3, 300 MHz): δ ϭ 1.90 (d, J ϭ
[6a] R. Hett, Q. K. Fang, Y. Gao, Y. Hong, H. T. Butler, X. Nie,
7.0 Hz, 3 H, CH3), 1.95 (m, 1 H, 4-H), 2.25 (m, 2 H, 3-H), 2.52
(m, 1 H, 4-H), 3.45 (m, 1 H, 1-H), 4.45 [m, 2 H, CH(Ph)CH3, 2-
H], 7.18 (m, 3 H, ArH), 7.62 (m, 2 H, ArH), 9.38 (br. s, 1 H,
NH2ϩ), 9.78 (br. s, 1 H, NH2ϩ). Ϫ 13C NMR (CDCl3, 75 MHz):
[6b]
S. A. Wald, Tetrahedron Lett. 1997, 38, 1125Ϫ1128. Ϫ
M.
H. Kress, C. Yang, N. Yasuda, E. J. J. Grabowski, Tetrahedron
Lett. 1997, 38, 2633Ϫ2636.
[7]
[8]
W. Hartmann, K.-H. Scholz, H.-G. Heine, Chem. Ber. 1980,
113, 1884Ϫ1889.
δ
ϭ 20.5 (CH3), 22.0 (C-4), 27.8 (C-3), 54.2 (C-1), 58.8
[8a] J. G. Cannon, T. Lee, V. Sankaran, J. Med. Chem. 1975, 18,
[8b]
[CH(Ph)CH3], 68.0 (C-2), 128.1 (ArC), 129.3 (ArC), 129.4 (ArC),
136.1 (ArC).
1027Ϫ1028. Ϫ
J. G. Cannon, D. M. Crockatt, J. P. Long,
W. Maixner, J. Med. Chem. 1982, 25, 1091Ϫ1094.
732
Eur. J. Org. Chem. 1998, 729Ϫ733